Does DROTAVERINE Cause Malignant neoplasm progression? 6 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Malignant neoplasm progression have been filed in association with DROTAVERINE. This represents 3.4% of all adverse event reports for DROTAVERINE.
6
Reports of Malignant neoplasm progression with DROTAVERINE
3.4%
of all DROTAVERINE reports
6
Deaths
6
Hospitalizations
How Dangerous Is Malignant neoplasm progression From DROTAVERINE?
Of the 6 reports, 6 (100.0%) resulted in death, 6 (100.0%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DROTAVERINE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does DROTAVERINE Cause?
Toxicity to various agents (54)
Drug interaction (48)
Pain (45)
Constipation (39)
Balance disorder (38)
Hypotension (38)
Off label use (36)
Cognitive disorder (35)
Dyspnoea (35)
Fall (34)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which DROTAVERINE Alternatives Have Lower Malignant neoplasm progression Risk?
DROTAVERINE vs DROXIDOPA
DROTAVERINE vs DULAGLUTIDE
DROTAVERINE vs DULERA
DROTAVERINE vs DULOXETINE
DROTAVERINE vs DUPILUMAB